$TMDX has experienced a notable increase in its stock price, rising by over 25% in just four days and more than 30% year-to-date. The stock, which was approximately $60 at the beginning of the year, has now surpassed $81. Analysts are optimistic about its potential for recovery and growth in 2025. The upcoming J.P. Morgan Healthcare Conference, starting January 13, 2025, is anticipated to provide further insights into the biotech sector, with several companies, including $VKTX, $BPMC, and $SRPT, expected to present. The conference will also feature discussions on various topics relevant to the healthcare industry, including new drug launches and collaborations. Key industry figures are preparing to attend and engage in discussions that could shape the future of biotech investments.